SCHEMBL16282701

SCHEMBL16282701

CC(=O)CCCCC(CCSCCc1ccccc1)SCCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.49
▸ TRPA1 O75762 1/20 0.41
▸ TRPV1 Q8NER1 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ CES1 P23141 1/20 0.38
▸ ALOX5 P09917 1/20 0.38
▸ MMP12 P39900 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ HDAC3 O15379 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ HDAC4 P56524 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HDAC7 Q8WUI4 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ HDAC10 Q969S8 1/20 0.38
▸ HDAC11 Q96DB2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10307746 0.89 MAPT (0.53) ALDH1A1MAPTRXFP1CES1MMP12
SCHEMBL17381367 0.86 CYP2C19 (0.49) ALDH1A1MMP13SMN1; SMN2CYP2C19LMNA
SCHEMBL22299026 0.85 CYP2C19 (0.48) ALDH1A1TRPA1TRPV1MAPTRXFP1
SCHEMBL15468646 0.84 CYSLTR2 (0.38) TRPA1TRPV1MAPTRXFP1CES1
SCHEMBL17973796 0.81 CYP2C19 (0.43) ALDH1A1MAPTMMP13SMN1; SMN2CYP2C19
SCHEMBL14027337 0.77 ALDH1A1 (0.38) ALDH1A1TRPA1TRPV1HDAC3HDAC4
SCHEMBL14027320 0.77 ALDH1A1 (0.42) ALDH1A1TRPA1TRPV1SMN1; SMN2CYP2C19
SCHEMBL21408461 0.75 HTT (0.48) ALDH1A1MAPTMAPK1SMN1; SMN2CYP1A2
Cpi 613 SCHEMBL13333201 0.75 CYP2C19 (0.59) ALDH1A1MAPTRXFP1HDAC3MAPK1
Cpi 613 SCHEMBL1062218 0.75 CYP2C19 (0.59) ALDH1A1MAPTRXFP1HDAC3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150509-B2 Lipoic acid derivatives CORNERSTONE PHARMACEUTICALS, INC. (US) 2015-10-06 — — US disclosed
US-20140364502-A1 LIPOIC ACID DERIVATIVES CORNERSTONE PHARMACEUTICALS, INC. 2014-12-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140364502-A1 LIPOIC ACID DERIVATIVES ALOX15, ALOX12, LIPC ALDH1A1 538/4885TRPA1 3994/4885TRPV1 3878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback